Evaluation of plasma biomarkers to predict major adverse kidney events in hospitalized patients with COVID-19

Authors

Steven Menez, Johns Hopkins University
Madhurima Kaushal, Washington University School of Medicine in St. Louis
Sanjay Jain, Washington University School of Medicine in St. Louis
et al.

Journal

American Journal of Kidney Diseases

Publication Date

9-1-2023

Volume

82

Issue

3

First Page

322

Last Page

332.e1

Document Type

Open Access Publication

DOI

10.1053/j.ajkd.2023.03.010

Rights and Permissions

Menez S, Coca SG, Moledina DG, Wen Y, Chan L, Thiessen-Philbrook H, Obeid W, Garibaldi BT, Azeloglu EU, Ugwuowo U, Sperati CJ, Arend LJ, Rosenberg AZ, Kaushal M, Jain S, Wilson FP, Parikh CR; TRIKIC Consortium. Evaluation of Plasma Biomarkers to Predict Major Adverse Kidney Events in Hospitalized Patients With COVID-19. Am J Kidney Dis. 2023 Sep;82(3):322-332.e1. doi: 10.1053/j.ajkd.2023.03.010. © 2023 by the National Kidney Foundation, Inc. Published by Elsevier Inc. This is an open access article under the CC BYNC-ND license (http:// creativecommons.org/ licenses/by-nc-nd/4.0/).

Recommended Citation

Menez, Steven; Kaushal, Madhurima; Jain, Sanjay; and et al., "Evaluation of plasma biomarkers to predict major adverse kidney events in hospitalized patients with COVID-19." American Journal of Kidney Diseases. 82, 3. 322 - 332.e1. (2023).
https://digitalcommons.wustl.edu/oa_4/2827

Department

ICTS (Institute of Clinical and Translational Sciences)

Additional Links

Supplemental material is available for this article at publisher site.